Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study of SYHX1901 tablets for moderate to severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SYHX1901

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Effects, Drug Side | Phase 2 | Status: COMPLETED